| Drug induced interstitial pneumonitis during FOLFOX4
chemotherapy for metastatic colorectal cancer |
| Jeung-seuk Yoon1, Dong-Guk Park1, Hwan Namgung1, Doh-hyung Kim2 |
1Department of Surgery, Division of Pulmonology and Allergy, Dankook University College of Medicine, Cheonan, Korea
2Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea |
| 전이성 대장암에서 FOLFOX4 항암 화학요법 시행 중 발생한 간질성 폐질환 1예 |
|
윤정석1, 박동국1, 남궁환1, 김도형2 |
1단국대학교 의과대학 외과학 교실
2단국대학교 의과대학 내과학 교실 |
| Corresponding Author:
Hwan Namgung ,Tel: ＋82-41-550-3929, Fax: ＋82-41-556-3878, Email: gsnamgung@dankook.ac.kr |
|
Received: March 29, 2012; Accepted: June 18, 2012. |
|
|
Share : 
|
| ABSTRACT |
|
FOLFOX4 regimen is one of the first line treatments for advanced colorectal cancer. Well known adverse effects are
neurological, hematologic, and gastro-intestinal toxicities. But recently, there were several case reports about
severe form pulmonary toxicity of this regimen. We herein report the case of an additional patient with FOLFOX4
induced interstitial lung disease. |
| Keywords:
Colorectal cancer | FOLFOX4 | Interstitial lung disease |
|
PDF Links
Full text via DOI
Download Citation 
